{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:43Z","timestamp":1783707403796,"version":"3.55.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Oral treatment with phosphodiesterase type 5 inhibitor (PDE5) is considered the first-line treatment for patients with erectile dysfunction (ED). Lodenafil carbonate (LC) is a novel PDE5.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This is a phase II, prospective, randomized, double-blind, and placebo controlled clinical trial of LC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Efficacy end points were International Index of Sexual Function (IIEF) erectile domain, IIEF questions 3 and 4, and Sexual Encounter Profile (SEP) questions 2 and 3, before and after the use of LC or placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seventy-two men older than 18 years, with ED for at least 6 months with stable sexual relationship were enrolled. Patients were randomized to placebo or LC 80 mg, 40 mg, or 20 mg and followed for 4 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>IIEF erectile domain scores before and after the use of medications were (mean \u00b1 standard deviation [SD]): placebo: 11.9 \u00b1 3.4 and 12.6 \u00b1 5.5; LC 20 mg: 15.8 \u00b1 4.1 and 18.9 \u00b1 6.6; LC 40 mg: 11.9 \u00b1 4.4 and 15.4 \u00b1 8.1; LC 80 mg: 14.2 \u00b1 4.7 and 22.8 \u00b1 6.0 (anovaP &amp;lt; 0.01). The SEP-2 scores before and after the use of medications were (Mean \u00b1 SD): placebo: 71.0 \u00b1 33.1 and 51.2 \u00b1 43.1; LC 20 mg 70.3 \u00b1 34.2 and 75.5 \u00b1 31.5; LC 40 mg: 48.4 \u00b1 42.1 and 60.8 \u00b1 42.5; LC 80 mg: 68.6 \u00b1 33.5 and 89.6 \u00b1 26.0. The SEP-3 scores were: placebo 23.3 \u00b1 27.6 and 33.6 \u00b1 42.3; LC 20 mg: 32.3 \u00b1 38.9 and 51.2 \u00b1 41.7; LC 40 mg: 39.7 \u00b1 44.7 and 46.7 \u00b1 41.1; LC 80 mg* 17.2 \u00b1 29.5 and 74.3 \u00b1 36.4 (*P &amp;lt; 0.05 for difference to placebo).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The drug was well tolerated. Adverse reactions were mild and self-limited and included headache, rhinitis, flushing, color visual disorders, and dyspepsia. This study showed that the dosage of 80 mg of LC was significantly more efficacious than placebo and well tolerated.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2008.01079.x","type":"journal-article","created":{"date-parts":[[2008,11,19]],"date-time":"2008-11-19T17:37:34Z","timestamp":1227116254000},"page":"553-557","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy and Tolerability of Lodenafil Carbonate for Oral Therapy in Erectile Dysfunction: A Phase II Clinical Trial"],"prefix":"10.1093","volume":"6","author":[{"given":"Sidney","family":"Glina","sequence":"first","affiliation":[{"name":"Hospital Ipiranga , S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iderpol","family":"Toscano","sequence":"additional","affiliation":[{"name":"Hospital Ipiranga , S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Gomatzky","sequence":"additional","affiliation":[{"name":"Hospital das Cl\u00ednicas da Universidade de S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pl\u00ednio Moreira","family":"De G\u00f3es","sequence":"additional","affiliation":[{"name":"Hospital das Cl\u00ednicas da Universidade de S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archimedes Nardozza","family":"J\u00fanior","sequence":"additional","affiliation":[{"name":"Hospital Ipiranga , S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Francisco de Almeida","family":"Claro","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Paulo\u2014Universidade Federal de S\u00e3o Paulo , S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Pagani","sequence":"additional","affiliation":[{"name":"Cristalia LTDA , S\u00e3o Paulo , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"key":"2024032521272772000_bb0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1743-6109.2007.00714.x","article-title":"Male erectile dysfunction and cardiovascular disease: Is there an intimate nexus?","volume":"5","author":"Chew","year":"2008","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1743-6109.2007.00602.x","article-title":"Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian men: The Asian men\u2019s attitudes to life events and sexuality (MALES) study","volume":"4","author":"Tan","year":"2007","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1743-6109.2007.00554.x","article-title":"Prevalence and risk factors for erectile dysfunction in Korean men: Results of an epidemiological study","volume":"4","author":"Ahn","year":"2007","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1743-6109.2006.00340.x","article-title":"Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: From the male attitudes regarding sexual health survey","volume":"4","author":"Laumann","year":"2007","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S1516-31802002000200005","article-title":"Prevalence and determinants of erectile dysfunction in Santos, southeastern","volume":"120","author":"Moreira","year":"2002","journal-title":"Brazil. Sao Paulo Med J"},{"key":"2024032521272772000_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S0104-42302006000600023","article-title":"Erectile dysfunction: Results of the Brazilian sexual life study","volume":"52","author":"Abdo","year":"2006","journal-title":"Rev Assoc Med Bras"},{"key":"2024032521272772000_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1743-6109.2006.00234.x","article-title":"Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial","volume":"3","author":"Althof","year":"2006","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0045","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1743-6109.2007.00441.x","article-title":"Erectile dysfunction: Monitoring response to treatment in clinical practice-recommendations of an international study panel","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"key":"2024032521272772000_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2008.06.055","article-title":"Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum","volume":"591","author":"Teixeira","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2024032521272772000_bb0055","first-page":"PC0593","article-title":"Toxicidade oral aguda do carbonato de lodenafila em camundongos. Int Braz","volume":"33","author":"Zincaglia","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"2024032521272772000_bb0060","first-page":"PC0606","article-title":"Toxicidade oral aguda do carbonato de lodenafila em c\u00e3es. Int Braz","volume":"33","author":"Taricano","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"2024032521272772000_bb0065","first-page":"PC0575","article-title":"Toxicidade doses repetidas para carbonato de lodenafila em ratos. Int Braz","volume":"33","author":"Zincaglia","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"2024032521272772000_bb0070","first-page":"PC0627","article-title":"Estudo cl\u00ednico fase I do carbonato de lodenafila em voluntarios sadios do sexo masculino","volume":"33","author":"De Nucci","year":"2007","journal-title":"Int Braz J Urol"},{"key":"2024032521272772000_bb0075","first-page":"425","article-title":"Lodenafil carbonate in the treatment of erectile dysfunction","volume":"64","author":"Lucio","year":"2007","journal-title":"Rev Bras Med"},{"key":"2024032521272772000_bb0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2024032521272772000_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pds.2630010207","article-title":"Causality classification in pharmacovigilance centers in the European community","volume":"1","author":"Meyboom","year":"1992","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024032521272772000_bb0090","author":"World Health Organization","journal-title":"Causality WHO-UMC Assessment System [on line]"},{"key":"2024032521272772000_bb0095","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032521272772000_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.ijir.3900631","article-title":"On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction","volume":"13","author":"Padma-Nathan","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032521272772000_bb0105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J Androl"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515323948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515323948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/6\/2\/553\/47109421\/jsm_6_2_553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/6\/2\/553\/47109421\/jsm_6_2_553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:27:54Z","timestamp":1711402074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/6\/2\/553\/6832488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,1]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2008.01079.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,2]]},"published":{"date-parts":[[2009,2,1]]}}}